Type 2 diabetes affects more than 300 million people globally, and as many as 15 per cent of those patients cannot take the first-line therapy metformin because of kidney damage risks.
Seeking a more viable path forward, researchers identified compounds that might counter the disease-associated gene expression changes associated with type 2 diabetes.
Also Read
The most promising chemical - sulforaphane, a naturally occurring compound found in cruciferous vegetables - tamped down glucose production by liver cells growing in culture, and shifted liver gene expression away from a diseased state in diabetic rats.
When the researchers gave concentrated broccoli sprout extracts to 97 human type 2 diabetes patients in a 12-week randomised placebo-controlled trial, obese participants who entered the study with dysregulated disease demonstrated significantly decreased fasting blood glucose levels compared to controls.
The researchers said that developing gene signatures to investigate large public repositories of gene expression data could be a valuable strategy to rapidly identify clinically relevant compounds.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)